Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2001;85:481-483; doi:10.1136/heart.85.5.481
Copyright © 2001 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2001;85:481-483 ( May )

Editorial

National Institute for Clinical Excellence guidance: too NICE to glycoprotein IIb/IIIa inhibitors?

The first 150 words of the full text of this article appear below.

The arrival of the National Institute for Clinical Excellence (NICE) in 1999 was greeted with suspicion by many clinicians who regarded it as the beginning of an era of overt health care rationing. From a cardiological perspective, this has not proved to be the case. The guidelines issued on implantable defibrillators, intracoronary stents, and glycoprotein (GP) IIb/IIIa inhibitors have been liberal and in the last instance surprising to many cardiologists.1 Given our original misgivings, it might seem churlish to complain about NICE's liberality, but an endorsement from NICE gives a treatment the appearance of an official seal of approval. This has important medico-legal implications and may also inhibit further research into the use and targeting of these compounds---no drug company is going to look such an attractive gift horse in the mouth and fund selective studies. Has NICE gone too far with GP IIb/IIIa inhibitors?

GP IIb/IIIa inhibitors are powerful . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Baker, C. S R (2004). Learning on the Web. Case 3: acute chest pain.. Heart 90: 112-112 [Full Text]  
  • Banning, A P, Ormerod, O J M, Channon, K, McKenna, C J, Orr, W, Boulton, B, Bashir, Y, Forfar, J C (2003). Same day discharge following elective percutaneous coronary intervention in patients with stable angina. Heart 89: 665-665 [Full Text]  
  • Niccoli, G, Banning, A P (2002). Heparin dose during percutaneous coronary intervention: how low dare we go?. Heart 88: 331-334 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.